Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about DK:NOVO/B

Recent news which mentions DK:NOVO/B

LifeMD’s stock soars 13% as company and Medifast to create weight-management program that includes GLP-1 drugs
Tickers LFMD LLY MED NVO
Tags LFMD DK:NOVO/B MED
From MarketWatch
Walmart seems to have changed its view of weight-loss drugs
Tickers GIS K KO LLY
Tags PEP DK:NOVO/B KO
From MarketWatch
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
Tickers LLY PFE WMT
Tags LLY CH:ROG PFE
From MarketWatch
Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
Tickers LLY NVO PFE SPX
Tags PFE DK:NOVO/B SPX
From MarketWatch
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade
Tickers AMGN ARKK BFIT COMP
Tags IHE DK:NOVO/B DJIA
From MarketWatch
Hedge funds plow cash into top tech stocks leading to record levels of crowding
Tickers AAPL ABT AMZN GOOG
Tags PODD AMZN AAPL
From MarketWatch
British Land leads U.K. real estate stocks higher amid optimism on rents
Tags UK:BA DK:NOVO/B UK:LAND
From MarketWatch
Weight-loss drug maker reports 56% profit surge, as it continues to limit supplies
Tickers LLY NVO
Tags DK:NOVO/B LLY NVO
From MarketWatch
Amgen’s stock hit by expectations its obesity pipeline is facing a longer wait
Tickers ABBV AMGN LLY NVO
Tags AMGN LLY ABBV
From MarketWatch
Who is having the most influence over your money in 2023? Meet the MarketWatch 50.
Tickers AAPL AMZN BRK-B DVA
Tags GOOGL SQ AAPL
From MarketWatch
The weight-loss drugs are coming for these companies — but here’s why Coke, others, may be spared, says JPMorgan
Tickers A AAPL AMC AVTR
Tags BX:TMUBMUSD02Y BRBR UBER
From MarketWatch
Here’s what Ozempic, ASML and India’s fintech industry all have in common — and how one ETF takes advantage of all three
Tickers ACWX ASML FERG HDB
Tags OSEA XX:899901 ACWX
From MarketWatch
What exactly are patients taking new weight-loss drugs eating and what are they avoiding? Bernstein asked them.
Tickers CPB GIS HSY K
Tags XLP DK:NOVO/B TWNK
From MarketWatch
DaVita plays down Ozempic’s potential in treating kidney disease
Tickers DVA SPX
Tags DVA DK:NOVO/B SPX
From MarketWatch
LVMH shares slump on sales miss, sending rival luxury-goods makers lower
Tags FR:MC UK:BP FR:PX1
From MarketWatch
Dialysis company shares plunge after Ozempic trial success vs. kidney trouble
Tickers FMS LLY NVS
Tags XE:FRE LLY FMS
From MarketWatch
Coca-Cola and PepsiCo’s stocks fall after Walmart says weight-loss drugs have customers cutting back on calories
Tickers LLY NVO PEP SPX
Tags WMT PEP DK:NOVO/B
From MarketWatch
This fund shows that industry expertise can help you make a lot of money in the stock market
Tickers ABBV ABT AKRO ETNB
Tags ABBV SPY LLY
From MarketWatch
Novo Nordisk, now Europe’s second-largest company by market cap, lifts outlook after 46% profit rise
Tickers NVO
Tags DK:NOVO/B NVO
From MarketWatch
Viking Therapeutics stock gets boost from positive news that obesity drugs reduced risk of heart attacks and strokes
Tickers LLY NVO SPX VKTX
Tags NVO SPX LLY
From MarketWatch
As obesity drugs help people eat less, these food companies could be the biggest losers
Tickers ACI BJ BRBR CAVA
Tags VITL MCD GO
From MarketWatch
Eli Lilly’s stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook
Tickers DJIA JNJ LLY MRK
Tags XPH JNJ SPX
From MarketWatch
Novo Nordisk’s Wegovy reduces risk of adverse cardiovascular events by 20% in obese adults
Tickers LLY NVO PFE
Tags PFE NVO LLY
From MarketWatch
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
Tickers ALT CTLT GPCR LLY
Tags PFE XE:GXI DK:ZEAL
From MarketWatch
EU regulator is reviewing weight-loss drugs Ozempic and Wegovy for risk of suicidal thoughts and self-harm
Tickers LLY PFE
Tags LLY DK:NOVO/B PFE
From MarketWatch
Ozempic and other weight-loss drugs boost pharmacy sales at Rite Aid
Tickers LLY PFE RAD
Tags LLY DK:NOVO/B RAD
From MarketWatch
Student-loan payments are coming back — and these are the stocks most at risk
Tickers AAPL AEO AMC BABA
Tags BURL XPEV JP:8031
From MarketWatch
Hit Wegovy weight-loss drug on track for $4 billion in U.S. sales despite supply constraints, analyst says
Tickers LLY NVO
Tags DK:NOVO/B LLY NVO
From MarketWatch
Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval
Tickers ETNB GNFT ICPT LLY
Tags GNFT TERN ICPT
From MarketWatch
Lilly’s ambitious diabetes drug Mounjaro fails to impress in the fourth quarter
Tickers LLY SPX
Tags DK:NOVO/B SPX LLY
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.